Stephen Mayo - 12 Mar 2026 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Director
Signature
/s/ Cristin L. Rothfuss, as Attorney-in-Fact for Stephen Mayo
Issuer symbol
SRPT
Transactions as of
12 Mar 2026
Net transactions value
-$123,208
Form type
4
Filing time
13 Mar 2026, 20:03:03 UTC
Previous filing
23 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mayo Stephen Director 215 FIRST STREET, SUITE 415, CAMBRIDGE /s/ Cristin L. Rothfuss, as Attorney-in-Fact for Stephen Mayo 13 Mar 2026 0001849061

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Sale $123,208 -7,239 -80% $17.02 1,765 12 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards.